SCHEMBL3134805

SCHEMBL3134805

CCOC(=O)c1ccc2c(c1)C(=C1CCN(C)CC1)c1ccccc1OC2

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SETD7 Q8WTS6 3/20 0.47
▸ MAPT P10636 3/20 0.46
▸ RXFP1 Q9HBX9 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ KCNH2 Q12809 1/20 0.45
▸ TP53 P04637 1/20 0.44
▸ DRD3 P35462 1/20 0.43
▸ HRH1 P35367 1/20 0.42
▸ RAB9A P51151 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3136931 0.92 SETD7 (0.44) SETD7MAPTRXFP1KDM4EALDH1A1
SCHEMBL3132994 0.89 SETD7 (0.45) SETD7MAPTRXFP1KDM4EALDH1A1
SCHEMBL11458444 0.87 SETD7 (0.57) SETD7MAPTKDM4EALDH1A1HPGD
SCHEMBL3138857 0.85 SETD7 (0.53) SETD7KCNH2HRH1
SCHEMBL3131301 0.82 KCNH2 (0.49) SETD7MAPTRXFP1KDM4EALDH1A1
SCHEMBL10809444 0.81 SETD7 (0.59) SETD7MAPTKDM4EALDH1A1KCNH2
SCHEMBL9718766 0.81 HRH1 (0.61) SETD7MAPTRXFP1KDM4EALDH1A1
SCHEMBL3138914 0.80 KCNH2 (0.44) SETD7MAPTKDM4EALDH1A1GAA
SCHEMBL3132987 0.80 SETD7 (0.46) SETD7KDM4EALDH1A1GAAHPGD
SCHEMBL14827214 0.80 KCNH2 (0.46) MAPTRXFP1KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2067777-B1 OXEPIN DERIVATIVE NIPPON ZOKI PHARMACEUTICAL CO (JP) 2013-08-14 — — EP disclosed
US-8222419-B2 Oxepin derivative NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2012-07-17 — — US disclosed
US-20100004456-A1 Oxepin derivative NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2010-01-07 — — US disclosed
EP-2067777-A1 OXEPIN DERIVATIVE Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2009-06-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004456-A1 Oxepin derivative HRH4, HRH3, HCRTR2 SETD7 2087/4885MAPT 4240/4885RXFP1 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback